We recommend using a combination of serum leptin and visfatin for the diagnosis and prediction of HCV associated HCC patients, as the sensitivity, specificity, PPV, NPV and accuracy were (100%, 96.6%, 93.4%, 100% and 97.4%; respectively). The gene discussed is NAMPT; the disease is hepatocellular carcinoma.